We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+1.45%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$4.82B
AUM Growth
-$16.7M
Cap. Flow
-$48.7M
Cap. Flow %
-1.01%
Top 10 Hldgs %
29.85%
Holding
402
New
19
Increased
71
Reduced
164
Closed
36

Top Sells

Rank Stock Value
1
ALIT icon
Alight
ALIT
+$41.6M
2
W icon
Wayfair
W
+$38.6M
3
LH icon
Labcorp
LH
+$36.1M
4
NSC icon
Norfolk Southern
NSC
+$32.9M
5
VRT icon
Vertiv
VRT
+$24.8M

Sector Composition

Rank Sector Weight
1 Technology 24.11%
2 Financials 14.3%
3 Consumer Discretionary 11.66%
4 Healthcare 11.12%
5 Communication Services 11.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLP icon
301
Alerian MLP ETF
AMLP
$12.9B
$328K 0.01%
+6,840
New +$320K
GBTC icon
302
Grayscale Bitcoin Trust
GBTC
$9.73B
$323K 0.01%
6,714
BDSX icon
303
Biodesix
BDSX
$221M
$315K 0.01%
10,280
SCHW
304
Charles Schwab
SCHW
$181B
$311K 0.01%
4,225
-3,581
-46% -$265K
PNC icon
305
PNC Financial Services
PNC
$99.2B
$311K 0.01%
2,001
-4,320
-68% -$670K
ALEC icon
306
Alector
ALEC
$180M
$298K 0.01%
65,663
-514
-0.8% -$2.65K
OEF icon
307
iShares S&P 100 ETF
OEF
$19.9B
$298K 0.01%
1,126
APA icon
308
APA Corp
APA
$12.8B
$296K 0.01%
10,050
VDC icon
309
Vanguard Consumer Staples ETF
VDC
$8B
$291K 0.01%
1,434
REYN icon
310
Reynolds Consumer Products
REYN
$5.32B
$291K 0.01%
10,400
GILD icon
311
Gilead Sciences
GILD
$163B
$290K 0.01%
4,225
HOLX
312
DELISTED
Hologic
HOLX
$282K 0.01%
3,794
RY icon
313
Royal Bank of Canada
RY
$292B
$278K 0.01%
2,611
MPC icon
314
Marathon Petroleum
MPC
$91.7B
$278K 0.01%
1,600
AOS icon
315
A.O. Smith
AOS
$8.24B
$276K 0.01%
3,379
-20
-0.6% -$1.69K
ZTS icon
316
Zoetis
ZTS
$31.9B
$276K 0.01%
1,592
DFS
317
DELISTED
Discover Financial Services
DFS
$275K 0.01%
+2,103
New +$262K
VIGI icon
318
Vanguard International Dividend Appreciation ETF
VIGI
$9.15B
$273K 0.01%
3,363
AZN icon
319
AstraZeneca
AZN
$266B
$258K 0.01%
1,655
IWO icon
320
iShares Russell 2000 Growth ETF
IWO
$14.4B
$255K 0.01%
970
MUSA icon
321
Murphy USA
MUSA
$11.4B
$254K 0.01%
541
-3
-0.6% -$1.31K
ARCC icon
322
Ares Capital
ARCC
$13.5B
$251K 0.01%
12,050
-1,100
-8% -$23K
LRCX icon
323
Lam Research
LRCX
$372B
$249K 0.01%
2,340
ALC icon
324
Alcon
ALC
$33.9B
$245K 0.01%
2,750
VLY icon
325
Valley National Bancorp
VLY
$7.92B
$244K 0.01%
35,000

Similar funds

Cannell & Spears's Q2 2024 Portfolio in Review

As of Q2 2024, Cannell & Spears held 402 positions worth $4.82B, down 0.34% from $4.84B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cannell & Spears's Q2 2024 filing shows 19 new, 71 increased, 164 reduced and 36 closed positions. Its largest new stake was Lamb Weston: 652,695 shares worth $54.9M. The largest sale was Alight, an estimated $41.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cannell & Spears's largest Q2 2024 buy was Lamb Weston: 652,695 shares worth $54.9M.
  • Cannell & Spears added most to Illumina in Q2 2024, an estimated $79.4M increase.
  • Cannell & Spears's biggest Q2 2024 reduction was Wayfair, cutting an estimated $38.6M.
  • Cannell & Spears fully exited Alight in Q2 2024, selling an estimated $41.6M.
  • Cannell & Spears's ten largest holdings make up 30% of its $4.82B portfolio in Q2 2024.
  • Cannell & Spears opened 19 new positions and closed 36 in Q2 2024.
  • Cannell & Spears's portfolio value fell 0.34% quarter-over-quarter to $4.82B.

Based on Cannell & Spears's 13F filing for Q2 2024, filed 12 Aug 2024.